At Thobari, J. 2021. Narrative Review: Risk-Benefit Hydroxychloroquine and Chloroquine in COVID-19. Indonesian Journal of Pharmacy. 32, 3 (Aug. 2021), 266-279. DOI:https://doi.org/10.22146/ijp.1187.